Pancreatic cancer is widely known as one of the most dangerous and difficult cancers to treat. Among the different types of pancreatic cancer, the most common and aggressive form is called pancreatic ...

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

For the first time in 30 years, there is a new FDA-approved treatment for locally advanced pancreatic cancer. Frederick Health is the first in the U.S. to bring this advancement to patients. It’s ...

Encouraging preclinical and translational data supporting DNase-based approaches to target NETs in difficult-to-treat ...

Cells behave like cities and organelles carry out infrastructural roles: mitochondria are powerhouses, the endoplasmic ...

For the first time in 30 years, there is a new FDA-approved treatment for locally advanced pancreatic cancer.

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors.

March is Colorectal Cancer Awareness Month and an ideal time to focus on the third most common cancer in the U.S. Many people know the importance of ...

Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced ...

Candel Therapeutics Inc (NASDAQ:CADL) is advancing plans to bring its lead cancer immunotherapy toward potential ...

Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, metastatic, non-squamous, non-small cell lung cancer ...